Platinum-resistant ovarian, peritoneal, or fallopian tube cancer

People with platinum-resistant ovarian, peritoneal, or fallopian tube cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.

You may be eligible to participate in this study if you:

• Are female and at least ≥ 18 of age
• Have ECOG performance status ≤2
• Are histologically or cytologically confirmed with high-grade serous epithelial ovarian carcinoma, fallopian tube, or peritoneal carcinoma
• Have adequate hematologic and organ function
• Have measurable disease per RECIST version 1.1

You may not participate in this study if you:

• Have histology of abdominal adenocarcinoma of unknown origin or diagnosis of a borderline ovarian tumor
• Had major surgery within 28 days
• Have received radiation therapy within 21 days
• Have received any systemic anti-cancer therapy
• Have active (uncontrolled, metastatic) second malignancies
• Have history or current evidence of congenital long QT syndrome
• Have an uncontrolled hypertension
• Have an active or uncontrolled infection
• Are pregnant, breast feeding or planning to become pregnant

Contact Information
Emmanuel Ugwu, Study Coordinator
325 West 15th Street, New York, New York 10011
Phone: (678) 308-0764